Gw Pharmaceuticals Plc. (PC) Stock Price - GWPRF

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Gw Pharmaceuticals Plc. (PC) GWPRF OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 11.00 0.00 0.00 0.00 11.00 20:00:00
Bid Price Ask Price Spread Spread % News
10.95 11.53 0.58 5.03% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Gw Pharmaceuticals Plc. (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.45B 131.55M $ -71.91M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
766.00 $ - 0.00% - -

more financials information »

Gw Pharmaceuticals Plc. (PC) News

Loading Messages....

Latest GWPRF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GWPRF Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week11.911.910.8511.36482k-0.9-7.56%
1 Month12.0412.810.8511.47453k-1.04-8.64%
3 Months14.05814.910.8512.85833k-3.058-21.75%
6 Months13.751610.8513.94544k-2.75-20.00%
1 Year13.17167.0713.03105k-2.17-16.48%
3 Years8.73167.0711.40545k2.2726.00%
5 Years7.131639.26787k3.8754.28%

Gw Pharmaceuticals Plc. (PC) Description

GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines, including Sativex(R) Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications. GW has assembled a large in-house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.